These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6504737)
1. [Preliminary evaluation of the results of treatment of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa)]. Juszczyk J Pol Tyg Lek; 1984 Aug; 39(33):1085-9. PubMed ID: 6504737 [No Abstract] [Full Text] [Related]
2. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Evaluation of the efficiency of cellular mechanisms of the immunologic response]. Dabrowska-Bernstein BK; Dabrowski MP; Stasiak A; Wasowska B; Brzosko WJ Pol Tyg Lek; 1984 Aug; 39(33):1091-6. PubMed ID: 6334280 [No Abstract] [Full Text] [Related]
3. [Immunotherapy of chronic active hepatitis (HBsAg+) with calf thymus extract (TFX-Polfa). Clinical evaluation]. Cianciara J; Babiuch L; Górska E; Kassur B Pol Tyg Lek; 1984 Aug; 39(33):1097-101. PubMed ID: 6390376 [No Abstract] [Full Text] [Related]
4. [Results of the treatment of chronic active hepatitis with thymus extract (TFX-Polfa). (Evaluation of the preliminary stage of clinical studies)]. Kiczka W; Juszczyk J; Adamek J Pol Tyg Lek; 1987 Feb; 42(7):192-6. PubMed ID: 3299322 [No Abstract] [Full Text] [Related]
5. Treatment with thymic extract TFX for chronic active hepatitis B. Dworniak D; Tchórzewski H; Pokoca L; Tkacz B; Drobnik S; Baj Z; Luciak M Arch Immunol Ther Exp (Warsz); 1991; 39(5-6):537-47. PubMed ID: 1841551 [TBL] [Abstract][Full Text] [Related]
6. [Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis]. Hinoue Y; Unoura M; Kato Y; Kobayashi K; Hattori N Gan To Kagaku Ryoho; 1984 Feb; 11(2):205-11. PubMed ID: 6696458 [TBL] [Abstract][Full Text] [Related]
7. [Favorable outcome in chronic active hepatitis caused by B virus in childhood]. Cadrobbi P; Bortolotti F; Crivellaro C; Rugge M; Armigliato M; Realdi G; Bertaggia A Minerva Pediatr; 1984 Jul; 36(13-14):685-9. PubMed ID: 6503897 [No Abstract] [Full Text] [Related]
8. Effect of thymic extract on allogeneic MLR and mitogen-induced responses in patients with chronic active hepatitis B. Zeman K; Dworniak D; Tchórzewski H; Pokoca L; Majewska E Immunol Invest; 1991 Dec; 20(7):545-55. PubMed ID: 1836778 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of thymostimulin treatment in hepatitis B surface antigen-positive chronic active liver disease. Results of a randomized clinical trial. Romeo F; Arcoria D; Palmisano L; Polosa P Arzneimittelforschung; 1985; 35(8):1317-22. PubMed ID: 3907642 [TBL] [Abstract][Full Text] [Related]
10. Attempt to treat acute type B hepatitis with an orally administered thymic extract (thymomodulin): preliminary results. Galli M; Crocchiolo P; Negri C; Caredda F; Lazzarin A; Moroni M Drugs Exp Clin Res; 1985; 11(9):665-9. PubMed ID: 3916838 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of chronic active HBsAg-positive hepatitis with thymostimulin]. Nardiello S; Russo M; Pizzella T; Galanti B; Giusti G G Ital Chemioter; 1984; 31(1-2):181-4. PubMed ID: 6468826 [No Abstract] [Full Text] [Related]
12. [Calf thymus extract (TFX-Polfa) in the treatment of pollinosis. Clinical trials by the double-blind method using a placebo]. Kowalski ML; Kuna P; Grzegorczyk J; Rozniecki J Pol Tyg Lek; 1987 Jun; 42(24):739-42. PubMed ID: 3313315 [No Abstract] [Full Text] [Related]
13. Treatment of fourteen chronic active HBsAg+, HBeAg+ hepatitis patients with low dose natural human interferon alpha administered orally. Zielińska W; Paszkiewicz J; Korczak A; Własiuk M; Zółtowska A; Szutowicz A; Cummins JM; Georgiades JA Arch Immunol Ther Exp (Warsz); 1993; 41(3-4):241-51. PubMed ID: 8129568 [TBL] [Abstract][Full Text] [Related]
14. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg. Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050 [TBL] [Abstract][Full Text] [Related]
15. The effect of long-term thymosine factor x/TFx/treatment on T lymphocyte subpopulations and peripheral blood mononuclear cell cytotoxicity in chronic active hepatitis B. Baj Z; Pokoca L; Tchórzewski H; Dworniak D; Tkacz B J Investig Allergol Clin Immunol; 1991 Aug; 1(4):239-46. PubMed ID: 1669583 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effectiveness of the immuno stimulating extract of the calf thymus (TFX-Polfa) in cases of acute dermatomyositis]. Stasiak A; Dudkiéwicz H; Dabrowski M; Dabrowska B; Wasowska B; Brzosko W Pol Tyg Lek; 1983 Mar; 38(13):389-92. PubMed ID: 6605525 [No Abstract] [Full Text] [Related]
17. [Interferon treatment in chronic hepatitis B]. Pastore G; Santantonio T; Milella M; Iacovazzi T; Longo A; Pietromatera G Minerva Gastroenterol Dietol; 1995 Mar; 41(1):97-102. PubMed ID: 7619970 [No Abstract] [Full Text] [Related]
18. Monoclonal antibody to HBsAg for chronic hepatitis B virus infection with hypogammaglobulinaemia. Lever AM; Waters J; Brook MG; Karayiannis P; Thomas HC Lancet; 1990 Jun; 335(8704):1529. PubMed ID: 1972457 [No Abstract] [Full Text] [Related]
19. [Effect of thymus extract TFX (Polfa) on hemoglobin level and peripheral blood erythrocyte count]. Lewandowicz J Pol Tyg Lek; 1990 Jun 4-11; 45(23-24):471-2. PubMed ID: 2277791 [TBL] [Abstract][Full Text] [Related]